| Application no. and date | 13851971.5 (espacenet) (Federated) (European Patent Register), 20131030 | | Patent/reg. no. and date | DK/EP 2914254, 20200108 | | Publication date | 20150909 | | Priority no. and date | US 201261720346 P, 20121030 | | EP pub. no. and date |
EP 2914254 20150909 | | Effective date | | | Applicant/owner | MEI Pharma, Inc., 11975 El Camino Real, Suite 101
San Diego, CA 92130, US | | Applicant ref. no. | P103242EP51 | | Inventor | GOLD, Daniel, P., 11975 El Camino Real
Suite 101
San Diego, CA 92130, US,
GARCIA-MANERO, Guillermo, c/o University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Box 428
Houston, TX 77030, US | | Representative | Pure Ideas Ltd, 25 Meer Street
Stratford-upon-Avon
Warwickshire
CV37 6QB, GB | | Opponent | | | IPC Class | A61K 31/245 (2006.01) , A61K 31/4184 (2006.01) , A61K 31/706 (2006.01) , A61K 31/7068 (2006.01) , A61K 31/708 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) | | Title | COMBINATION THERAPIES TO TREAT CHEMORESISTANT CANCERS | | Int. application no. | US2013067607 | | Int. publication no. | WO2014070948 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
